Literature DB >> 6263305

Melphalan uptake in relation to vascular and extracellular space of human lung-tumour xenografts.

E Wist, J L Millar, A J Shorthouse.   

Abstract

The effect of melphalan on the growth of 4 different lines of human lung-tumour xenografts has been established. The oat-cell carcinoma was the most sensitive, whereas the adenocarcinoma was the most resistant. Two lines of large-cell anaplastic carcinomas were intermediate in sensitivity. The differences in sensitivity were not reflected in the gross uptake of drug into the tumours. There was, with the exception of the adenocarcinoma line, a marked decrease in uptake per g tumour with increasing tumour size. This was partly caused by a decrease in the vascular supply in the same tumours with increasing tumour size. Extravasation of plasma proteins increased with increasing tumour size in all tumours, but was much less pronounced in the adenocarcinoma than in the other tumour lines. The extracellular volume of the various tumour lines did not vary with tumour size.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263305      PMCID: PMC2010633          DOI: 10.1038/bjc.1981.67

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  6 in total

1.  In vivo studies with hexamethylmelamine.

Authors:  C J Rutty; T A Connors; H Hoellinger
Journal:  Eur J Cancer       Date:  1978-06       Impact factor: 9.162

2.  Quantitative study of vascularity in Walker carcinoma 256.

Authors:  C W Song; S H Levitt
Journal:  Cancer Res       Date:  1971-05       Impact factor: 12.701

3.  Vascular and extravascular spaces in two transplantable tumors of the rat.

Authors:  L Appelgren; H I Peterson; B Rosengren
Journal:  Bibl Anat       Date:  1973

4.  The therapeutic response of three human tumor lines maintained in immune-suppressed mice.

Authors:  L Kopper; G G Steel
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

Review 5.  The growth and therapeutic response of human tumours in immune deficient mice.

Authors:  G G Steel
Journal:  Bull Cancer       Date:  1978       Impact factor: 1.276

6.  The human tumour xenograft--a valid model in experimental chemotherapy?

Authors:  A J Shorthouse; J F Smyth; G G Steel; M Ellison; J Mills; M J Peckham
Journal:  Br J Surg       Date:  1980-10       Impact factor: 6.939

  6 in total
  4 in total

Review 1.  Human tumor xenografts as model for drug testing.

Authors:  J Mattern; M Bak; E W Hahn; M Volm
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

Review 2.  Predictive tests in cancer chemotherapy. A reappraisal.

Authors:  R Osieka; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-03-01

3.  High dose cyclophosphamide treatment of human oat cell xenografts in immune deprived mice.

Authors:  B D Evans; I E Smith; J L Millar
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

4.  Induced and inherent resistance to alkylating agents in human small-cell bronchial carcinoma xenografts.

Authors:  R Berman; G G Steel
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.